12/01/2019 01:32:21

The National Ovarian Cancer Coalition names Melissa Aucoin Chief Executive Officer

Dallas, TX, Jan. 11, 2019 (GLOBE NEWSWIRE) -- Dallas, TX January 11, 2019 — The Board of Directors of The National Ovarian Cancer Coalition is pleased to announce the selection of Melissa Aucoin as its new Chief Executive Officer. Melissa has been serving in the capacity of interim CEO since June 2018 and was formerly Director of Events and Operations since April 2017.

During her time as the Director of National Events & Operations for the NOCC, she was responsible for the growth and development of the organization's national events, including the signature fundraising series, Run/Walk to Break the Silence on Ovarian Cancer®. Additionally, she provides daily operational oversight to the Headquarters office in Dallas, Texas. During this time of transition, Melissa has demonstrated outstanding leadership, vision and drive in line with our mission and purpose through her work. Under her direction, the organization has seen substantial growth in revenues, grassroots initiatives that support Survivors and their families, and elevated brand awareness.

Dr. Meredith Mitstifer, chair and ovarian cancer Survivor states, “Melissa has demonstrated meaningful impact since her arrival to NOCC. Her experience, drive and transformational leadership skills are exemplary. The board is incredibly honored and ecstatic at her new appointment. Melissa is passionate, dedicated and genuinely authentic and we look forward to her continued contributions to NOCC.”

As an industry veteran, Melissa brings nearly two decades of expertise in a large- scale nonprofit environment to the organization and is a team-focused leader with a deep passion for women’s health.

“I am beyond honored to have this opportunity to continue to lead and serve an organization that fights so tirelessly for the strong and courageous women impacted by ovarian cancer and I will work diligently each day to be an agent of change in this fight.” said Aucoin. “We’ve accomplished so much this last year united in our mission, and I am confident that together we will continue to heighten awareness, improve the quality of life for our Survivors and their families, and reach new advances in treatment and research.”

Please join us in welcoming Melissa Aucoin as the incoming CEO.


About the National Ovarian Cancer Coalition

For more than 25 years, the National Ovarian Cancer Coalition has been committed to raising awareness, promoting education, and funding research in support of women, families, and communities touched by ovarian cancer. The NOCC is well established as an important national advocate for patients and families struggling with ovarian cancer. The NOCC remains steadfast in its mission “to save lives by fighting tirelessly to prevent and cure ovarian cancer and to improve the quality of life for survivors.” For more information, please visit


or call 888.OVARIAN (888-682-7426) and follow the NOCC on




, and



Melissa Aucoin

National Ovarian Cancer Coalition




Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
19 Mar
Hejsa Lidt forårs opdatering. Langsigtet konjunkturmodel: Nederst kan I se den langsigtede konjunktu..
13 Mar
Skam dig selv. Jeg synes faktisk dit udsagn er urimeligt. Vedkommende har i god tro købt lidt aktier..
18 Mar
SAS's emmision overtegnet så de regner med 15MUSD i provenu samlet - godt nyt for GOMSpace hvis de k..
14 Mar
Elliot.Blot for info så har jeg cirka 14.000 timer på 737 serien og der er altid problemer når en ty..
19 Mar
  Studiet er et randomiseret fase 4 forsøg, hvor man sammenligner forlænget frigivelse Envarsus XR (..
14 Mar
Danske Bank er sværd at værdiansætte set i forhold til den situation som Danske Bank befinder sig i...
13 Mar
Der er nogle enkelt punkter som jeg har noteret mig under læsningen af Årsrapporten 2018 samt de sen..
Jeg skrev til IR vedr. lidt forskelligt, her er deres svar:  Bliver der afholdt en Capital Market D..
18 Mar
For mig virker det ret underligt at udmelding fra FDA om ydereligere 3mdr mere behandlingstid bliver..
15 Mar
Det forhold, at Pandora på trods af negativ analyse fra Carnegie og udbetaling af udbytte har holdt ..


EuroInvestor: In Focus


EuroInvestor: In Focus


EuroInvestor: In Focus

Most read news

  • 24 hours
  • 48 hours
  • 1 week
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Health Insurance, Conagra, Kraft Heinz, and Diplomat and Encourages Investors to Contact the Firm
PDAC welcomes Federal Budget 2019
PureCircle Launches Next Generation Stevia Leaf Sweeteners in Singapore
NanoString Technologies Announces Pricing of Public Offering of 4,500,000 Shares of Common Stock
Dermira Prices $130.0 Million Public Offering of Common Stock

Latest news

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
20 March 2019 20:14:13
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190320.1 - EUROWEB3 - 2019-03-20 21:14:13 - 2019-03-20 20:14:13 - 1000 - Website: OKAY